ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $86,229 (100.0% shares, 0.0% debt)

Holdings (34)

OCUL OCULAR THERAPEUTIX INC 10.4%

Value ($000) $8,941 Shares 1,219,724 Est. Cost $5.33 Unrealized +44.3%

INSM INSMED INC 9.4%

Value ($000) $8,092 Shares 106,074 Est. Cost $43.95 Unrealized +74.1%

— TOURMALINE BIO INC 7.5%

Value ($000) $6,493 Shares 426,882 Est. Cost $23.42 Unrealized —

WHWK WHITEHAWK THERAPEUTICS INC 7.0%

Value ($000) $6,071 Shares 3,410,402 Est. Cost $16.10 Unrealized -83.8%

ELVN ENLIVEN THERAPEUTICS INC 6.1%

Value ($000) $5,220 Shares 265,269 Est. Cost $16.47 Unrealized +30.7%

TRVI TREVI THERAPEUTICS INC 5.7%

Value ($000) $4,944 Shares 785,961 Est. Cost $3.08 Unrealized +54.9%

SLNO SOLENO THERAPEUTICS INC 5.6%

Value ($000) $4,797 Shares 67,136 Est. Cost $48.69 Unrealized 0.0%

ARGX ARGENX SE 4.8%

Value ($000) $4,157 Shares 7,023 Est. Cost $489.55 Unrealized —

ASND ASCENDIS PHA-ADR 4.2%

Value ($000) $3,638 Shares 23,340 Est. Cost $148.43 Unrealized —

PRAX PRAXIS PRECISION MEDICINES I 3.8%

Value ($000) $3,300 Shares 87,141 Est. Cost $34.51 Unrealized +81.0%

— CIDARA THERAPEUTICS INC 3.1%

Value ($000) $2,708 Shares 125,708 Est. Cost $23.85 Unrealized —

OCS OCULIS HOLDING AG 2.8%

Value ($000) $2,379 Shares 125,000 Est. Cost $20.50 Unrealized 0.0%

RVMD REVOLUTION MEDICINES INC 2.7%

Value ($000) $2,357 Shares 66,662 Est. Cost $24.90 Unrealized +63.0%

LQDA LIQUIDIA CORPORATION 2.6%

Value ($000) $2,264 Shares 153,482 Est. Cost $11.30 Unrealized +29.1%

DRUG BRIGHT MINDS BIOSCIENCES INC 2.5%

Value ($000) $2,155 Shares 59,748 Est. Cost $35.19 Unrealized +4.0%

BBOT HELIX ACQUISITION CORP II 2.5%

Value ($000) $2,116 Shares 187,257 Est. Cost $10.30 Unrealized +4.3%

MRK MERCK & CO 2.4%

Value ($000) $2,064 Shares 22,994 Est. Cost $90.12 Unrealized 0.0%

SRZN SURROZEN INC 2.3%

Value ($000) $1,982 Shares 170,000 Est. Cost $11.62 Unrealized 0.0%

EWTX EDGEWISE THERAPEUTICS INC 2.2%

Value ($000) $1,880 Shares 85,454 Est. Cost $23.25 Unrealized +12.8%

MREO MEREO BIOPHARMA GROUP PL-ADR 2.1%

Value ($000) $1,782 Shares 791,815 Est. Cost $3.72 Unrealized —

— UNICYCIVE THERAPEUTICS INC 1.6%

Value ($000) $1,353 Shares 2,352,887 Est. Cost $0.46 Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 1.4%

Value ($000) $1,189 Shares 9,575 Est. Cost $130.46 Unrealized 0.0%

VSTM VERASTEM INC 1.2%

Value ($000) $1,061 Shares 176,000 Est. Cost $6.11 Unrealized 0.0%

GILD GILEAD SCIENCES INC 1.2%

Value ($000) $1,042 Shares 9,298 Est. Cost $73.51 Unrealized +36.8%

TERN TERNS PHARMACEUTICALS INC 1.0%

Value ($000) $899 Shares 325,550 Est. Cost $6.33 Unrealized -35.4%

ZYME ZYMEWORKS INC 0.9%

Value ($000) $815 Shares 68,459 Est. Cost $13.98 Unrealized -2.4%

RARE ULTRAGENYX PHARMACEUTICAL INC 0.9%

Value ($000) $771 Shares 21,290 Est. Cost $50.81 Unrealized -18.1%

— VERVE THERAPEUTICS INC 0.9%

Value ($000) $744 Shares 162,724 Est. Cost $4.91 Unrealized —

RCKT ROCKET PHARMACEUTICALS INC 0.6%

Value ($000) $556 Shares 83,350 Est. Cost $18.58 Unrealized -46.8%

RAPP RAPPORT THERAPEUTICS INC 0.2%

Value ($000) $164 Shares 16,400 Est. Cost $23.15 Unrealized -43.9%

FBRX FORTE BIOSCIENCES INC 0.2%

Value ($000) $143 Shares 18,469 Est. Cost $11.89 Unrealized -0.8%

ARTV ARTIVA BIOTHERAPEUTICS INC 0.2%

Value ($000) $136 Shares 45,456 Est. Cost $11.39 Unrealized -52.6%

— NUVATION BIO INC -CW27 0.0%

Value ($000) $17 Shares 90,832 Est. Cost $0.28 Unrealized —

— ENLIVEN THERAPEUTICS INC 0.0%

Value ($000) $0 Shares 115,805 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
OCUL	OCULAR THERAPEUTIX INC	1,219,724	$8,941	10.4%	$5.33	+44.3%	COM	67576A100
INSM	INSMED INC	106,074	$8,092	9.4%	$43.95	+74.1%	COM PAR $.01	457669307
—	TOURMALINE BIO INC	426,882	$6,493	7.5%	$23.42	—	COM	89157D105
WHWK	WHITEHAWK THERAPEUTICS INC	3,410,402	$6,071	7.0%	$16.10	-83.8%	COM	00032Q104
ELVN	ENLIVEN THERAPEUTICS INC	265,269	$5,220	6.1%	$16.47	+30.7%	COM	29337E102
TRVI	TREVI THERAPEUTICS INC	785,961	$4,944	5.7%	$3.08	+54.9%	COM	89532M101
SLNO	SOLENO THERAPEUTICS INC	67,136	$4,797	5.6%	$48.69	0.0%	COM	834203309
ARGX	ARGENX SE	7,023	$4,157	4.8%	$489.55	—	SPONSORED ADR	04016X101
ASND	ASCENDIS PHA-ADR	23,340	$3,638	4.2%	$148.43	—	SPONSORED ADR	04351P101
PRAX	PRAXIS PRECISION MEDICINES I	87,141	$3,300	3.8%	$34.51	+81.0%	COM	74006W207
—	CIDARA THERAPEUTICS INC	125,708	$2,708	3.1%	$23.85	—	COM NEW	171757206
OCS	OCULIS HOLDING AG	125,000	$2,379	2.8%	$20.50	0.0%	ORDINARY SHARES	H5870P102
RVMD	REVOLUTION MEDICINES INC	66,662	$2,357	2.7%	$24.90	+63.0%	COM	76155X100
LQDA	LIQUIDIA CORPORATION	153,482	$2,264	2.6%	$11.30	+29.1%	COM NEW	53635D202
DRUG	BRIGHT MINDS BIOSCIENCES INC	59,748	$2,155	2.5%	$35.19	+4.0%	COM NEW	10919W405
BBOT	HELIX ACQUISITION CORP II	187,257	$2,116	2.5%	$10.30	+4.3%	CL A ORD SHS	G4444H101
MRK	MERCK & CO	22,994	$2,064	2.4%	$90.12	0.0%	COM	58933Y105
SRZN	SURROZEN INC	170,000	$1,982	2.3%	$11.62	0.0%	COM NEW	86889P208
EWTX	EDGEWISE THERAPEUTICS INC	85,454	$1,880	2.2%	$23.25	+12.8%	COM	28036F105
MREO	MEREO BIOPHARMA GROUP PL-ADR	791,815	$1,782	2.1%	$3.72	—	SPON ADS	589492107
—	UNICYCIVE THERAPEUTICS INC	2,352,887	$1,353	1.6%	$0.46	—	COM	90466Y103
JAZZ	JAZZ PHARMACEUTICALS PLC	9,575	$1,189	1.4%	$130.46	0.0%	SHS USD	G50871105
VSTM	VERASTEM INC	176,000	$1,061	1.2%	$6.11	0.0%	COM NEW	92337C203
GILD	GILEAD SCIENCES INC	9,298	$1,042	1.2%	$73.51	+36.8%	COM	375558103
TERN	TERNS PHARMACEUTICALS INC	325,550	$899	1.0%	$6.33	-35.4%	COM	880881107
ZYME	ZYMEWORKS INC	68,459	$815	0.9%	$13.98	-2.4%	COM	98985Y108
RARE	ULTRAGENYX PHARMACEUTICAL INC	21,290	$771	0.9%	$50.81	-18.1%	COM	90400D108
—	VERVE THERAPEUTICS INC	162,724	$744	0.9%	$4.91	—	COM	92539P101
RCKT	ROCKET PHARMACEUTICALS INC	83,350	$556	0.6%	$18.58	-46.8%	COM	77313F106
RAPP	RAPPORT THERAPEUTICS INC	16,400	$164	0.2%	$23.15	-43.9%	COM	75383L102
FBRX	FORTE BIOSCIENCES INC	18,469	$143	0.2%	$11.89	-0.8%	COM NEW	34962G208
ARTV	ARTIVA BIOTHERAPEUTICS INC	45,456	$136	0.2%	$11.39	-52.6%	COM	04317A107
—	NUVATION BIO INC -CW27	90,832	$17	0.0%	$0.28	—	*W EXP 07/07/2027	67080N119
—	ENLIVEN THERAPEUTICS INC	115,805	$0	0.0%	—	—	COM	452CVR012